Skin Analytics is a UK-based medical AI company, founded in 2012, that builds autonomous AI for skin cancer detection. Its main product, DERM, is a Class III CE-marked AI medical device that assesses dermoscopic images of skin lesions and decides whether a patient can be safely discharged or needs to see a specialist. It is mostly used in NHS urgent suspected skin cancer pathways, backed by the company’s own teledermatology platform for dermatologist review. DERM Zero, launched in June 2026, brings the same technology to smartphone photos, so primary care and community providers can run checks without a dermoscope. The vendor reports more than 40 NHS partners and over 250,000 patient assessments. It is built for NHS trusts, health systems and insurers rather than individual clinicians. Pricing is not publicly listed; interested organizations are directed to contact the team or book a demo.
Audrey
2026-11-05Skin Analytics is doing some great work, especially given how overwhelmed dermatology services can be! The idea of using AI to help identify which skin lesions actually need to be seen by a specialist makes a lot of sense, and I like that the company is focusing on making the process quicker rather than trying to replace doctors entirely. My main question would be how consistently the AI performs across different skin tones and how much healthcare providers can realistically save by implementing it.